S&P Futures
4,168.75 -22.75 (-0.54%) Dow Futures
34,102.00 +5.00 (+0.01%) Nasdaq Futures
12,648.50 -198.25 (-1.54%) Russell 2000 Futures
2,006.30 -1.60 (-0.08%) Crude Oil
75.77 -0.11 (-0.14%) Gold
1,928.50 -2.30 (-0.12%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 55.75 |
| Open | 56.21 |
| Bid | 41.03 x 800 |
| Ask | 73.17 x 800 |
| Day's Range | 56.21 - 58.07 |
| 52 Week Range | 41.82 - 88.00 |
| Volume | |
| Avg. Volume | 412,088 |
| Market Cap | 3.107B |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.97 |
| Earnings Date | Feb 22, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 72.17 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for LIVN
Related Research
- LivaNova PLCLIVN: Raising target price to $59.00LIVANOVA PLC has an Investment Rating of HOLD; a target price of $59.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.RatingFair ValueEconomic Moat2 days agoArgus Research
- Business Wire
LivaNova Launches SenTiva DUO
LONDON, February 02, 2023--LivaNova launched SenTiva DUO™, an implantable pulse generator with a dual-pin header to provide VNS Therapy™ for drug-resistant epilepsy treatment.
- Reuters
CORRECTED-FDA classifies recall of LivaNova's blood-pumping system controller as most serious
The U.S. Food and Drug Administration on Friday classified the recall of LivaNova's device that controls a blood-pumping system at its most serious type, citing that their use could cause serious injuries or death. The medical device company recalled 589 units of the LifeSPARC system's controller, through the period of Dec. 19, 2019 to Nov. 17, 2022, for a software update to address a previously known malfunction. The controller's software malfunction may trigger the device to enter critical failure mode causing the pump to stop for an extended time period, the FDA said, which may lead to serious injury or death of the patient.
- Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
LONDON, January 18, 2023--LivaNova PLC will host a conference call to discuss its fourth-quarter and full-year 2022 results on Feb. 22, 2023 at 1 p.m. London time (8 a.m. ET).
